Device / Technology News

RSS

Osprey Medical closes IPO raising of A$20 million

Osprey Medical Inc, has today announced that its Initial Public Offer (IPO) raising of A$20 million has closed. Osprey Medical’s Offer was well supported by institutional and retail investors in Australia, including founding investors CM Capital and Brandon Capital. The Initial Public Offer was underwritten by Shaw Corporate Finance.

17 Apr 2012

St. Jude Medical's Ellipse ICD receives CE Mark Approval

St. Jude Medical, Inc., a global medical device company, today announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator (ICD). Designed with feedback from more than 200 physicians from around the world, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.

16 Apr 2012

Conformetrix's NMR-based technology to be applied across AstraZeneca's pre-clinical therapeutic pipeline

Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.

16 Apr 2012

Web-based decision guide reduces uncertainty about breast cancer prevention options

When women at high risk of breast cancer viewed a customized web-based decision guide about prevention options, they were more likely to make a choice about prevention and to feel comfortable with their choice, a new study finds.

16 Apr 2012

Tool predicts response to platinum-based chemotherapy in ovarian cancer

A DNA repair pathway-focused score has the potential to help determine if first-line platinum based chemotherapy can benefit advanced-stage ovarian cancer patients, according to a study published April 13 in the Journal of the National Cancer Institute.

16 Apr 2012

MDI to advance Detect-Ready MRSA Panel with $1.9M Series B recapitalization financing

Molecular Detection Inc., a company developing Detect-Ready® tests designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has completed a $1.9 million Series B recapitalization financing.

16 Apr 2012

Implantable device with alert modes warns users about potential heart attack

More than 30% of the one million heart attack victims in the United States each year die before seeking medical attention. Although widespread education campaigns describe the warning signs of a heart attack, the average time from the onset of symptoms to arrival at the hospital has remained at 3 hours for more than 10 years.

16 Apr 2012

New project to help control jet noise in tactical aircraft

The deafening roar of supersonic aircraft can cause hearing damage to Sailors and Marines on flight decks, so the Office of Naval Research (ONR) is funding a new project to help reduce jet noise, officials announced April 12.

16 Apr 2012

Research roundup: Obesity treatment for low-income patients; Medicare vs. private plans

Low-income patients are underrepresented in clinical trials and are disproportionately prone to obesity and the related problems of high blood pressure and heart disease. Researchers conducted a 24-month trial of more than 300 low-income, obese patients from various Boston community health centers, randomizing participants "to usual care or a behavioral intervention that promoted weight loss and hypertension self-management using eHealth components. The intervention included tailored behavior change goals, self-monitoring, and skills training, available via a website or interactive voice response."

16 Apr 2012

CT guided transthoracic fine needle aspiration might diagnose pulmonary nodules

Screening for lung cancer with low dose CT scans has been shown to save lives. However, research shows that when CT scans reveal nodules in the lungs, it is not cancerous 96 percent of the time. As a result, scientists are looking for ways to more accurately make a diagnosis. One way is by using a CT guided transthoracic fine needle aspiration.

16 Apr 2012

Florbetaben PET scan reliably identifies beta-Amyloid in the brain

Piramal Imaging SA, a newly formed subsidiary of Piramal Healthcare Limited, announced positive first results from a Phase III study that showed that PET imaging with florbetaben reliably detects beta-Amyloid in the brain during life with great accuracy and thus shows value as a potential tool to aid in the diagnosis and assessment of Alzheimer's disease.

16 Apr 2012

Study identifies potential biomarkers associated with chemo resistant breast cancers

Biomarkers which could help to predict resistance to chemotherapy in breast cancer patients have been identified by researchers from the University of Hull, UK.

16 Apr 2012

Chin implants fastest growing plastic surgery trend among all major demographics

New statistics released today by the American Society of Plastic Surgeons (ASPS) show that chin augmentation is the fastest growing plastic surgery trend among all major demographics -- a phenomenon which appears, in part, to be sparked by increased usage of video chat technology, an aging baby boomer population and a desire for success in the workplace.

16 Apr 2012

New technique could help improve prognosis of patients with brain cancers

Like special-forces troops laser-tagging targets for a bomber pilot, tiny particles that can be imaged three different ways at once have enabled Stanford University School of Medicine scientists to remove brain tumors from mice with unprecedented accuracy.

16 Apr 2012

FDA approves HUD designation for SynCardia temporary Total Artificial Heart for destination therapy

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the U.S. Food and Drug Administration has approved a Humanitarian Use Device (HUD) designation for the SynCardia temporary Total Artificial Heart to be used for destination therapy in addition to its current PMA approval as a bridge to transplant.

12 Apr 2012

Longer looks: Diagnosing autism in minutes; Finding new uses for old drugs; Cancer war victories

Autism is an extremely complex diagnosis. Parental insight, physician observations and hours of data can factor into determining whether a child actually has the condition or is just a little on the quirky side. Now a Harvard researcher, Dennis P. Wall, has published research about a Web-based tool he developed that promises to diagnose autism in minutes, not hours -

12 Apr 2012

New image-guided radiotherapy system at DMC Huron Valley-Sinai Hospital

A new image-guided radiotherapy system will be dedicated on Thurs., April 19, 2012 at DMC Huron Valley-Sinai Hospital. The TrueBeam system treats cancer more effectively through highly precise targeting of lung, breast, prostate, and head and neck tumors.

12 Apr 2012

U-Systems receives positive FDA panel review for somo•v ABUS system for breast cancer screening

U-Systems, the leader in automated breast ultrasound, today announced that the U.S. Food and Drug Administration's Radiological Devices Panel of the Medical Devices Advisory Committee recommended approval of the somo•v Automated Breast Ultrasound (ABUS) system.

12 Apr 2012

OptiMedica's Catalys Precision Laser System receives CE mark approval

Global ophthalmic company OptiMedica Corp. has announced that its Catalys Precision Laser System has been CE mark approved for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

12 Apr 2012

Novian Health commences multicenter Novilase Interstitial Laser Therapy clinical trial for breast cancer

Novian Health, developer of Novilase Breast Therapy, announced the company has begun a multicenter clinical trial on the use of Novilase Interstitial Laser Therapy (ILT) for the destruction of malignant breast tumors.

12 Apr 2012

Device / Technology News

Osprey Medical closes IPO raising of A$20 million

St. Jude Medical's Ellipse ICD receives CE Mark Approval

Conformetrix's NMR-based technology to be applied across AstraZeneca's pre-clinical therapeutic pipeline

Web-based decision guide reduces uncertainty about breast cancer prevention options

Tool predicts response to platinum-based chemotherapy in ovarian cancer

MDI to advance Detect-Ready MRSA Panel with $1.9M Series B recapitalization financing

Implantable device with alert modes warns users about potential heart attack

New project to help control jet noise in tactical aircraft

Research roundup: Obesity treatment for low-income patients; Medicare vs. private plans

CT guided transthoracic fine needle aspiration might diagnose pulmonary nodules

Florbetaben PET scan reliably identifies beta-Amyloid in the brain

Study identifies potential biomarkers associated with chemo resistant breast cancers

Chin implants fastest growing plastic surgery trend among all major demographics

New technique could help improve prognosis of patients with brain cancers

FDA approves HUD designation for SynCardia temporary Total Artificial Heart for destination therapy

Longer looks: Diagnosing autism in minutes; Finding new uses for old drugs; Cancer war victories

New image-guided radiotherapy system at DMC Huron Valley-Sinai Hospital

U-Systems receives positive FDA panel review for somo•v ABUS system for breast cancer screening

OptiMedica's Catalys Precision Laser System receives CE mark approval

Novian Health commences multicenter Novilase Interstitial Laser Therapy clinical trial for breast cancer

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News